[Cardiovascular risk evaluation in the treatment of Hodgkin lymphoma-are we on the road to individualized planning?].
作者信息
Oertel Michael, Eich Hans Theodor
机构信息
Klinik für Strahlentherapie - Radioonkologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland.
出版信息
Strahlenther Onkol. 2023 Mar;199(3):333-336. doi: 10.1007/s00066-023-02051-3. Epub 2023 Feb 7.
Abstract
摘要
相似文献
1
[Cardiovascular risk evaluation in the treatment of Hodgkin lymphoma-are we on the road to individualized planning?].[霍奇金淋巴瘤治疗中的心血管风险评估——我们正走向个体化规划之路吗？]
Strahlenther Onkol. 2023 Mar;199(3):333-336. doi: 10.1007/s00066-023-02051-3. Epub 2023 Feb 7.
2
Radiation Therapy for Treatment of Adolescent and Young Adult Hodgkin Lymphoma and Risk for Cardiovascular Disease and Cancer.青少年及年轻成人霍奇金淋巴瘤的放射治疗与心血管疾病和癌症风险。
J Adolesc Young Adult Oncol. 2019 Feb;8(1):1-8. doi: 10.1089/jayao.2018.0060. Epub 2018 Sep 15.
3
Recommendations for the use of radiotherapy in nodal lymphoma.结外淋巴瘤放疗推荐。
Clin Oncol (R Coll Radiol). 2013 Jan;25(1):49-58. doi: 10.1016/j.clon.2012.07.011. Epub 2012 Aug 11.
4
Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?放射治疗在晚期霍奇金淋巴瘤或非霍奇金淋巴瘤中起作用吗？
Curr Treat Options Oncol. 2016 Jan;17(1):4. doi: 10.1007/s11864-015-0377-x.
5
Modern radiotherapeutic strategies in the management of lymphoma.淋巴瘤治疗中的现代放射治疗策略。
Future Oncol. 2015;11(6):1011-20. doi: 10.2217/fon.14.305.
6
[Radiotherapy of lymphomas. Clinical classification, radiotherapy planning and indications].
Radiol Med. 1976 Jul-Aug;62(7-8):542-7.
7
Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.一线使用环磷酰胺、阿霉素、长春新碱和泼尼松（CHOP）或CHOP联合利妥昔单抗（R-CHOP）治疗的非霍奇金淋巴瘤患者的心血管不良事件：一项系统评价和荟萃分析。
Lancet Haematol. 2020 Apr;7(4):e295-e308. doi: 10.1016/S2352-3026(20)30031-4. Epub 2020 Mar 2.
8
[Therapy of malignant lymphoma].
Dtsch Med Wochenschr. 1990 May 11;115(19):743-8. doi: 10.1055/s-2007-1024446.
9
Radiotherapy of Hodgkin and Non-Hodgkin Lymphoma: A Nonrigid Image-Based Registration Method for Automatic Localization of Prechemotherapy Gross Tumor Volume.
Technol Cancer Res Treat. 2016 Apr;15(2):355-64. doi: 10.1177/1533034615582290. Epub 2015 Apr 26.
10
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.接受调强放射治疗的霍奇金淋巴瘤和非霍奇金淋巴瘤患者放射性肺炎的预测因素
Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):175-82. doi: 10.1016/j.ijrobp.2015.02.010.
引用本文的文献
1
Impact of Modern Low Dose Involved Site Radiation Therapy on Normal Tissue Toxicity in Cervicothoracic Non-Hodgkin Lymphomas: A Biophysical Study.现代低剂量累及野放射治疗对颈胸段非霍奇金淋巴瘤正常组织毒性的影响：一项生物物理学研究
Cancers (Basel). 2023 Dec 5;15(24):5712. doi: 10.3390/cancers15245712.
本文引用的文献
1
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era.德国霍奇金淋巴瘤研究组HD 16和HD 17试验中的放射治疗：现代霍奇金淋巴瘤的质量保证与剂量分析
Adv Radiat Oncol. 2022 Dec 30;8(3):101169. doi: 10.1016/j.adro.2022.101169. eCollection 2023 May-Jun.
2
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.英国 NCRI RAPID 试验中，正电子发射断层扫描指导早期霍奇金淋巴瘤治疗的化疗和放疗后心血管疾病的预测风险。
J Clin Oncol. 2021 Nov 10;39(32):3591-3601. doi: 10.1200/JCO.21.00408. Epub 2021 Aug 13.
3
Late Sequelae of Radiotherapy—The Effect of Technical and Conceptual Innovations in Radiation Oncology.放疗的晚期后遗症——放射肿瘤学中技术和理念创新的影响。
Dtsch Arztebl Int. 2021 Mar 26;118(12):205-211. doi: 10.3238/arztebl.m2021.0024.
4
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.PET 引导的早期不利型霍奇金淋巴瘤放疗省略（GHSG HD17）：一项多中心、开放标签、随机、3 期临床试验。
Lancet Oncol. 2021 Feb;22(2):223-234. doi: 10.1016/S1470-2045(20)30601-X.
5
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin's lymphoma.放射技术对纵隔 Hodgkin 淋巴瘤患者肺毒性的影响。
Strahlenther Onkol. 2021 Jan;197(1):56-62. doi: 10.1007/s00066-020-01682-0. Epub 2020 Sep 18.
6
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.正电子发射断层扫描指导早期有利型霍奇金淋巴瘤治疗：德国霍奇金研究组国际、随机 III 期 HD16 试验的最终结果。
J Clin Oncol. 2019 Nov 1;37(31):2835-2845. doi: 10.1200/JCO.19.00964. Epub 2019 Sep 10.
7
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.早期正电子发射断层扫描反应适应性治疗 I 期和 II 期霍奇金淋巴瘤：随机 EORTC/LYSA/FIL H10 试验的最终结果。
J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14.
8
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.早期霍奇金淋巴瘤的 PET 导向治疗试验结果。
N Engl J Med. 2015 Apr 23;372(17):1598-607. doi: 10.1056/NEJMoa1408648.
Zotero 插件